Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients
J Clin Exp Hematop
.
2023;63(3):205-208.
doi: 10.3960/jslrt.23024.
Authors
Masuho Saburi
1
,
Yosuke Kodama
1
,
Keiichi Uraisami
1
,
Hiroyuki Takata
1
,
Yasuhiko Miyazaki
1
,
Takumi Nishikawa
2
,
Hitohiro Sasaki
2
,
Miyuki Abe
2
,
Kazuhiro Kohno
2
,
Junpei Wada
3
,
Shogo Urabe
3
,
Yoshiyuki Kondo
4
,
Toshiyuki Nakayama
2
,
Eiichi Ohtsuka
1
Affiliations
1
Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
2
Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan.
3
Department of Pathology, Oita Prefectural Hospital, Oita, Japan.
4
Department of Pathology, Oita Kouseiren Tsurumi Hospital, Oita, Japan.
PMID:
37766565
PMCID:
PMC10628821
DOI:
10.3960/jslrt.23024
No abstract available
Keywords:
mantle cell lymphoma; outcome; real-world practice; treatment.
MeSH terms
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Lymphoma, Mantle-Cell* / pathology
Treatment Outcome